HCPLive

Top Medical News Today

Ticagrelor More Beneficial to Patients En Route Hospital
Administering ST-segment elevation myocardial infarction (STEMI) patients ticagrelor in the ambulance was reported to safely reduced ischemic events 24 hours following primary percutaneous coronary intervention (PCI).
Early diagnosis continues to be one of the biggest challenges associated with rheumatoid arthritis (RA); however, researchers have identified a genetic marker that can predict tissue damage severity that could lead to better treatments.
Specialists agree that a condition unofficially known as asthma-COPD overlap syndrome (ACOS) exists, according to a survey completed by Marc Miravitlles, MD, and colleagues. The participants were 26 specialists in either asthma or chronic obstructive pulmonary disease (COPD practicing in Spain. They first completed a structured questionnaire, and then attended an in-person work meeting that followed the Metaplan technique.
People with pulmonary arterial hypertension may benefit from initial combination therapy with ambrisentan and tadalafil, according to a recent study published in the New England Journal of Medicine
Cardiovascular diseases (CVDs) cause more than 52% of all deaths in females, according to the World Health Organization (WHO), and myocardial infarction (MI) incidence is increasing in the younger population.
Close relatives or friends often serve as surrogate decision-makers for patients in intensive care units. Physicians are usually comfortable answering their medical questions. But what happens when spiritual or religious issues arise in the context of end-of-life decisions?
The glucose-lowering medication lixisenatide was found not to increase or decrease cardiovascular (CV) events compare with placebo in patients afflicted with type 2 diabetes and acute coronary syndrome.

Features

Resources for Your Patients

Click here for the latest hepatitis C news and updates for patients

Most Popular

Recent Published Journal

$vacMongoViewPlus$ $vAR$